메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Endan Li (CHA University) Jiwoo Choi (CHA University) Hye-Ri Sim (Chong Kun Dang Pharmaceutical Corp.) Jiyeon Kim (CHA University) Jae Hyun Jun (CHA University) Jangbeen Kyung (Chong Kun Dang Pharmaceutical Corp.) Nina Ha (Chong Kun Dang Pharmaceutical Corp.) Keun Ho Ryu (Chong Kun Dang Pharmaceutical Corp.) Seung Soo Chung (Yonsei University College of Medicine) Hyun Sook Kim (CHA University) Semi Kim (Chong Kun Dang Pharmaceutical Corp.) Sungsu Lee (iPS Bio Inc.) Wongi Seol (iPS Bio Inc.) 송지환 (주식회사 아이피에스바이오)
저널정보
대한생화학·분자생물학회 BMB Reports BMB Reports 제56권 제3호
발행연도
2023.3
수록면
178 - 183 (6page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Huntington’s disease (HD) is a neurodegenerative disorder, ofwhich pathogenesis is caused by a polyglutamine expansion inthe amino-terminus of huntingtin gene that resulted in the aggregationof mutant HTT proteins. HD is characterized by progressivemotor dysfunction, cognitive impairment and neuropsychiatricdisturbances. Histone deacetylase 6 (HDAC6), amicrotubule-associated deacetylase, has been shown to inducetransport- and release-defect phenotypes in HD models, whilsttreatment with HDAC6 inhibitors ameliorates the phenotypiceffects of HD by increasing the levels of α-tubulin acetylation,as well as decreasing the accumulation of mutant huntingtin(mHTT) aggregates, suggesting HDAC6 inhibitor as a HD therapeutics. In this study, we employed in vitro neural stem cell(NSC) model and in vivo YAC128 transgenic (TG) mouse modelof HD to test the effect of a novel HDAC6 selective inhibitor,CKD-504, developed by Chong Kun Dang (CKD PharmaceuticalCorp., Korea). We found that treatment of CKD-504 increasedtubulin acetylation, microtubule stabilization, axonaltransport, and the decrease of mutant huntingtin protein invitro. From in vivo study, we observed CKD-504 improved thepathology of Huntington’s disease: alleviated behavioral deficits,increased axonal transport and number of neurons, restoredsynaptic function in corticostriatal (CS) circuit, reduced mHTTaccumulation, inflammation and tau hyperphosphorylation inYAC128 TG mouse model. These novel results highlight CKD-504as a potential therapeutic strategy in HD.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0